TFAP2C increases ERBB-related genes (EGFR, ERBB2, ERBB3), which mediate oncogenesis in ERBB2/HER2-amplified breast cancer [106, 108, 117–119, 121–123]. The gene discussed is EGFR; the disease is breast carcinoma.